AI Genomics Lab - 1000 Tests/Day - Turnkey Sale

EXECUTIVE SUMMARY
Turn Key Lab/ BioTech company offering a rare opportunity to acquire a fully operational, revenue-generating clinical genomics laboratory with cutting-edge AI-powered testing capabilities and extensive nationwide payer contracts.
Key Investment Highlights:

$2M+ in State-of-the-Art Equipment - Fully depreciated assets
50+ Active Payer Contracts across 45 states
High-Complexity CLIA Certified - Ready for immediate operations
AI Platform - Proprietary automated reporting system
1,000+ Tests/Day Capacity - Massive scalability potential
Prime Chicago Location - Relocatable to any market

LABORATORY CAPABILITIES
Advanced Testing Portfolio

Equipment & Technology Assets

High-throughput genotyping platforms
Automated Sample Processing - Opentrons robotics systems
PCR & Amplification Systems - Complete molecular diagnostics suite
AI Software Platform - Enterprise value $500K+
Quality Control Systems - ISO 15189 compliant infrastructure
Data Management Systems - HIPAA/GDPR compliant

REVENUE & PAYER CONTRACTS
Nationwide Insurance Coverage
Government Programs:
Medicare (National Coverage)
40+ State Medicaid Programs
Commercial Insurance:
Blue Cross Blue Shield (10+ states)
UnitedHealthcare
Aetna
Cigna
Humana
Molina (Multiple states)
Active State Coverage:
Illinois, Indiana, Texas, Florida, California, New York, Pennsylvania, Ohio, Michigan, Wisconsin, Colorado, Arizona, Utah, Oklahoma, Missouri, Maryland, Virginia, North Carolina, South Carolina, Tennessee, Kentucky, Nevada, Washington, New Jersey, West Virginia
Revenue Potential:

Average reimbursement: $600-18,500 per test
Monthly capacity: 20,000+ tests
Projected annual revenue: $30-100M at full utilization
Current Global contracts value: $10M+ annually

COMPLIANCE & CERTIFICATIONS
Regulatory Credentials:

High-Complexity CLIA Certification (#14D2148056)
CAP Accreditation Ready
ISO 15189 Compliant Protocols
HIPAA & GDPR Compliant

BUSINESS ADVANTAGES
Why This Opportunity is Unique:
1. Immediate Cash Flow

Active payer contracts generating revenue
No credentialing wait times
Established referral networks

2. Scalability

Equipment capacity for 1,000+ tests daily
Expandable to additional states
Ready for telehealth integration

3. Market Position

Growing demand for pharmacogenomics (30% CAGR)
Mental health genomics explosion post-COVID
Personalized medicine mainstream adoption

4. Operational Excellence

Turnkey operations with trained staff available
Established SOPs and protocols
Proven billing and collections processes


FINANCIAL OVERVIEW
Asset Valuation:

Laboratory Equipment: $2,000,000+
Software & IP: $500,000
Payer Contracts: $4,000,000+ value
Total Enterprise Value: $6.5M+

Operating Metrics:

Gross margins: 65-75%
EBITDA potential: 40-50%
Payback period: 12-18 months at full utilization